Back to Journals » Clinical Ophthalmology » Volume 11

Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction [Corrigendum]

Authors Muñoz Negrete FJ, Lemij HG, Erb C

Received 31 March 2017

Accepted for publication 31 March 2017

Published 11 May 2017 Volume 2017:11 Pages 887—888

DOI https://doi.org/10.2147/OPTH.S138482

Muñoz Negrete FJ, Lemij HG, Erb C. Clinical Ophthalmology. 2017;11:557–566.

On page 557, Abstract, the second sentence “This multicenter, international (Belgium, the Netherlands, and Spain), epidemiological convenience sample survey among patients commencing treatment with preservative-free latanoprost collected data on patient satisfaction with particular regard to tolerability” should read “This multicenter, international (Germany, the Netherlands, and Spain), epidemiological convenience sample survey among patients commencing with preservative-free latanoprost collected data on patient satisfaction with particular regard to tolerability”.

On page 558, Methods section, Inclusion criteria subheading, 1st sentence, the drug name Monoprost® should have been Monopost®.

On page 559, Methods section, Analysis of variables subheading, 2nd paragraph, 1st sentence, the drug name Monoprost® should have been Monopost®.

Read the original article


Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other articles by this author:

Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction

Muñoz Negrete FJ, Lemij HG, Erb C

Clinical Ophthalmology 2017, 11:557-566

Published Date: 21 March 2017

Patient satisfaction with glaucoma therapy: reality or myth?

Lemij HG, Hoevenaars JGMM, van der Windt C, Baudouin C

Clinical Ophthalmology 2015, 9:785-793

Published Date: 4 May 2015

A 3-day regimen with azithromycin 1.5% eyedrops for the treatment of purulent bacterial conjunctivitis in children: efficacy on clinical signs and impact on the burden of illness

Bremond-Gignac D, Messaoud R, Lazreg S, Speeg-Schatz C, Renault D, Chiambaretta F

Clinical Ophthalmology 2015, 9:725-732

Published Date: 20 April 2015

A randomized crossover study comparing trehalose/hyaluronate eyedrops and standard treatment: patient satisfaction in the treatment of dry eye syndrome

Pinto-Bonilla JC, del Olmo-Jimeno A, Llovet-Osuna F, Hernández-Galilea E

Therapeutics and Clinical Risk Management 2015, 11:595-603

Published Date: 13 April 2015

European survey on the opinion and use of micronutrition in age-related macular degeneration: 10 years on from the Age-Related Eye Disease Study

Aslam T, Delcourt C, Holz F, García-Layana A, Leys A, Silva RM, Souied E

Clinical Ophthalmology 2014, 8:2045-2053

Published Date: 10 October 2014

Evaluation of the efficacy, safety, and acceptability of an eyelid warming device for the treatment of meibomian gland dysfunction

Benitez del Castillo JM, Kaercher T, Mansour K, Wylegala E, Dua H

Clinical Ophthalmology 2014, 8:2019-2027

Published Date: 6 October 2014

Latanoprost in the treatment of glaucoma

Alm A

Clinical Ophthalmology 2014, 8:1967-1985

Published Date: 26 September 2014

Use of preservative-free hyaluronic acid (Hylabak®) for a range of patients with dry eye syndrome: experience in Russia

Brzhesky VV, Maychuk YF, Petrayevsky AV, Nagorsky PG

Clinical Ophthalmology 2014, 8:1169-1177

Published Date: 18 June 2014

Topical azithromycin or ofloxacin for endophthalmitis prophylaxis after intravitreal injection

Romero-Aroca P, Sararols L, Arias L, Casaroli-Marano RP, Bassaganyas F

Clinical Ophthalmology 2012, 6:1595-1599

Published Date: 9 October 2012

Tolerability and acceptability of Blephagel: a novel eyelid hygiene aqueous gel

Doan S

Clinical Ophthalmology 2012, 6:71-77

Published Date: 11 January 2012

Do neurologists in Germany adhere to the national Parkinson's disease guideline?

Sabrina Schröder, Daniel Kuessner, Guy Arnold, et al

Neuropsychiatric Disease and Treatment 2011, 7:103-110

Published Date: 7 March 2011